LifeVantage (NASDAQ:LFVN) Updates FY 2024 Earnings Guidance

LifeVantage (NASDAQ:LFVNGet Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share guidance of 0.570-0.670 for the period, compared to the consensus earnings per share estimate of 0.600. The company issued revenue guidance of $202.0 million-$205.0 million, compared to the consensus revenue estimate of $209.3 million.

LifeVantage Trading Up 7.5 %

Shares of LifeVantage stock opened at $6.57 on Monday. The company has a 50-day moving average of $6.51 and a two-hundred day moving average of $6.37. The stock has a market cap of $83.44 million, a PE ratio of 23.46 and a beta of 0.80. LifeVantage has a 12-month low of $3.04 and a 12-month high of $8.69.

LifeVantage Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Friday, May 31st will be issued a dividend of $0.04 per share. The ex-dividend date is Friday, May 31st. This is a boost from LifeVantage’s previous quarterly dividend of $0.04. This represents a $0.16 annualized dividend and a yield of 2.44%. LifeVantage’s payout ratio is currently 50.00%.

About LifeVantage

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Further Reading

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.